Literature DB >> 33346370

First-in-human radiofrequency ablation of ventricular tachycardia performed through an Atrial Flow Regulator device.

Mateusz Wilkowski1, Łukasz Lewicki2,3, Rafał Olszewski1, Adam Priebe3, Miłosz J Jaguszewski2, Marek Szołkiewicz3.   

Abstract

Entities:  

Year:  2020        PMID： 33346370      PMCID： PMC8105063          DOI： 10.5603/CJ.a2020.0172

Source DB:  PubMed          Journal:  Cardiol J        ISSN： 1898-018X            Impact factor:   2.737


× No keyword cloud information.
  3 in total

1.  The AFR-PRELIEVE trial: a prospective, non-randomised, pilot study to assess the Atrial Flow Regulator (AFR) in heart failure patients with either preserved or reduced ejection fraction.

Authors:  Christina Paitazoglou; Ramazan Özdemir; Roman Pfister; Martin W Bergmann; Jozef Bartunek; Teoman Kilic; Alexander Lauten; Alexander Schmeisser; Mehdi Zoghi; Stefan Anker; Horst Sievert; Felix Mahfoud
Journal:  EuroIntervention       Date:  2019-08-29       Impact factor: 6.534

2.  Atrial flow regulator as a novel therapy for patients with chronic heart failure.

Authors:  Łukasz Lewicki; Robert Sabiniewicz; Janusz Siebert; Marek Szołkiewicz
Journal:  Cardiol J       Date:  2020-05-21       Impact factor: 2.737

Review 3.  Electrical Storm in Patients with Implantable Cardioverter-defibrillators: A Practical Overview.

Authors:  Daniele Muser; Jackson J Liang; Pasquale Santangeli
Journal:  J Innov Card Rhythm Manag       Date:  2017-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.